Literature DB >> 25117217

ELISPOT Techniques.

Niannian Ji1, Thomas G Forsthuber.   

Abstract

The enzyme-linked immunospot (ELISPOT) assay is a widely used method for enumerating antigen-specific cytokine-producing or antibody-secreting immune cells. It is one of the most effective immunological and diagnostic approaches to detect and quantify low-frequency cytokine- or antibody-producing cells in human and animal tissues, such as peripheral blood, lymph nodes, and spleen. Detection and quantification of specific cytokine-producing cells by the ELISPOT assay is based on the formation of visible spots at the site of cytokine release by the cells under investigation (e.g., T cells) using pairs of different capture and detection antibodies under optimized conditions.Here we focus mainly on practical, optimized protocols for cytokine ELISPOT assays for detection of mouse and human cytokine-producing immune cells (e.g., peripheral blood mononuclear cells, PBMC), including suggestions for trouble-shooting and optimizing steps for problematic tissue samples.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 25117217     DOI: 10.1007/7651_2014_111

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  8 in total

1.  Production of Oral Vaccines Based on Virus-Like Particles Pseudotyped with Protozoan-Surface Proteins.

Authors:  Lucía Lara Rupil; Marianela Del Carmen Serradell; Hugo Daniel Luján
Journal:  Methods Mol Biol       Date:  2022

2.  Dose Dependent Antimicrobial Cellular Cytotoxicity-Implications for ex vivo Diagnostics.

Authors:  Ana Copaescu; Phuti Choshi; Sarah Pedretti; Effie Mouhtouris; Jonathan Peter; Jason A Trubiano
Journal:  Front Pharmacol       Date:  2021-08-10       Impact factor: 5.988

3.  Therapeutic Potential of Immunoproteasome Inhibition in Duchenne Muscular Dystrophy.

Authors:  Andrea Farini; Clementina Sitzia; Barbara Cassani; Letizia Cassinelli; Rosita Rigoni; Federica Colleoni; Nicola Fusco; Stefano Gatti; Pamela Bella; Chiara Villa; Filomena Napolitano; Rita Maiavacca; Silvano Bosari; Anna Villa; Yvan Torrente
Journal:  Mol Ther       Date:  2016-08-10       Impact factor: 11.454

4.  Adaptive Immune Response Impairs the Efficacy of Autologous Transplantation of Engineered Stem Cells in Dystrophic Dogs.

Authors:  Clementina Sitzia; Andrea Farini; Luciana Jardim; Paola Razini; Marzia Belicchi; Letizia Cassinelli; Chiara Villa; Silvia Erratico; Daniele Parolini; Pamela Bella; Joao Carlos da Silva Bizario; Luis Garcia; Marcelo Dias-Baruffi; Mirella Meregalli; Yvan Torrente
Journal:  Mol Ther       Date:  2016-08-10       Impact factor: 11.454

5.  Glucan particles as a novel adjuvant for the induction of experimental autoimmune encephalomyelitis.

Authors:  Carol Chase Huizar; Niannian Ji; Robert Reddick; Gary R Ostroff; Thomas G Forsthuber
Journal:  Cell Immunol       Date:  2021-05-21       Impact factor: 4.178

6.  Development of an in-house SARS-CoV-2 interferon-gamma ELISpot and plate reader-free spot detection method.

Authors:  Willem A Mak; Johannes G M Koeleman; David S Y Ong
Journal:  J Virol Methods       Date:  2021-12-01       Impact factor: 2.014

Review 7.  A Systematic Review of T Cell Epitopes Defined from the Proteome of Hepatitis B Virus.

Authors:  Yandan Wu; Yan Ding; Chuanlai Shen
Journal:  Vaccines (Basel)       Date:  2022-02-08

8.  Integrative Analysis of HTNV Glycoprotein Derived MHC II Epitopes by In Silico Prediction and Experimental Validation.

Authors:  Hao Sun; Zhenhua Lu; Guoyun Xuan; Ning Liu; Tianhu Wang; Yang Liu; Mingfu Lan; Jiahao Xu; Yuancai Feng; Shuang Xu; Yuchen Lu; Baozeng Sun; Jinpeng Zhang; Xiyang Zhang; Yuanjie Sun; Shuya Yang; Yun Zhang; Yusi Zhang; Linfeng Cheng; Dongbo Jiang; Kun Yang
Journal:  Front Cell Infect Microbiol       Date:  2021-07-19       Impact factor: 5.293

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.